Skip to main content
. 2022 Sep 20;41:279. doi: 10.1186/s13046-022-02481-4

Table 2.

Clinical and demographic characteristics of subjects according to HPV status

All patients HPV-negative HPV-positive
n (%) n (%) n (%) p-value
Age (years)
 Median (range) 61 (51–85) 59 (52–85) 62 (51–85) .599
Sex
 Woman 16 (41.0) 4 (26.7) 12 (50.0) .150
 Man 23 (59.0) 11 (73.3) 12 (50.0)
Tobacco smoking
 Never 11 (28.2) 0 (0.0) 11 (45.8) .020
 Ever 28 (71.8) 15 (100.0) 13 (54.02)
Alcohol drinking
 Never 21 (53.8) 6 (40.0) 15 (62.5) .141
 Ever 18 (46.2) 9 (60.0) 9 (37.5)
Sub-site
 Base of tongue 7 (17.9) 3 (20.0) 4 (16.7) .792
 Tonsil 32 (82.1) 12 (80.0) 20 (83.3)
pTa
 T1 10 (25.6) 2 (13.3) 8 (33.3) .146
 T2 14 (35.9) 4 (26.7) 10 (41.7)
 T3 9 (23.1) 6 (40.0) 3 (12.5)
 T4 6 (15.4) 3 (20.0) 3 (12.5)
pNa
 N1 21 (53.8) 3 (20.0) 18 (75.0) .001
 N2 14 (35.9) 8 (53.3) 6 (25.0)
 N3 4 (10.3) 4 (26.7) 0 (0.0)
pStagea
 I 13 (33.3) 0 (0.0) 13 (33.3) <.000
 II 10 (25.6) 0 (0.0) 10 (25.6)
 III 3 (7.7) 2 (13.3) 1 (4.2)
 IV 13 (33.3) 13 (86.7) 0 (0.0)
Grading
 G2 16 (41.0) 9 (60.0) 7 (29.2) .058
 G3 23 (59.0) 6 (40.0) 17 (70.8)
Adjuvant treatment
 None 12 (30.8) 2 (13.3) 10 (41.7) .083
 (Chemo)-radiotherapy 27 (69.2) 13 (86.7) 14 (58.3)

a According to TNM classification 8th edition, 2017